http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007116597-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2007-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2007116597-A1 |
| titleOfInvention | Tumor marker, tumor diagnostic kit, method for measuring tumor marker and tumor diagnostic method |
| abstract | It provides tumor markers that are both sensitive and specific. The tumor marker of the present invention comprises at least one of human-derived Sideroflex, anti-human-derived Sideroflexin antibody, human-derived Sideroflexin gene, and mRNA of the gene. Said human-derived Sideroflexin is preferably Sideroflexin-3. The antibody is preferably an autoantibody in serum. For example, if autoantibodies in the serum of a subject are measured by ELISA using recombinant Sideroflexin-3 as an antigen, cancer can be determined with high sensitivity and high specificity as shown in the graph of FIG. |
| priorityDate | 2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.